HER3/ErbB3 Antibody

About the Target

ERBB3 is a target of interest in many antibody-based workflows. HER3 is a member of the HER (EGFR/ErbB) receptor family, which includes EGFR, HER2, HER3, and HER4. Unlike the other members with active tyrosine kinase domains, HER3 lacks intrinsic kinase activity. Despite this, HER3 is crucial in drug resistance to EGFR- and HER2-targeting therapies. Depending on the literature source, ERBB3 may also be discussed as HER3/ErbB3 and ErbB3/HER3.

Reported cellular context includes cell membrane, membrane, and secreted, which can matter when signal is compared across treatments or changing cell states. Following ERBB3 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

ERBB3 is commonly interpreted in the context of cancer and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, membrane, and secreted, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cell membrane, membrane, and secreted across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation
• co-patterning with orthogonal markers and control conditions that clarify pathway state

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for ERBB3. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in ERBB3 reflect biology rather than handling. When interpreting ERBB3, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep ERBB3 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.